192 related articles for article (PubMed ID: 32636772)
41. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
[TBL] [Abstract][Full Text] [Related]
42. Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study.
Rocha RB; Dondossola ER; Grande AJ; Colonetti T; Ceretta LB; Passos IC; Quevedo J; da Rosa MI
J Psychiatr Res; 2016 Dec; 83():47-53. PubMed ID: 27552533
[TBL] [Abstract][Full Text] [Related]
43. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
[TBL] [Abstract][Full Text] [Related]
44. Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome.
van Zutphen EM; Rhebergen D; van Exel E; Oudega ML; Bouckaert F; Sienaert P; Vandenbulcke M; Stek M; Dols A
Transl Psychiatry; 2019 May; 9(1):155. PubMed ID: 31127089
[TBL] [Abstract][Full Text] [Related]
45. Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression.
Järventausta K; Sorri A; Kampman O; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E; Peltola J; Lehtimäki K
Acta Psychiatr Scand; 2017 Jan; 135(1):87-92. PubMed ID: 27858966
[TBL] [Abstract][Full Text] [Related]
46. Reorganization of Anatomical Connectome following Electroconvulsive Therapy in Major Depressive Disorder.
Zeng J; Luo Q; Du L; Liao W; Li Y; Liu H; Liu D; Fu Y; Qiu H; Li X; Qiu T; Meng H
Neural Plast; 2015; 2015():271674. PubMed ID: 26770836
[TBL] [Abstract][Full Text] [Related]
47. Retrospective evaluation of the dexamethasone suppression test as a predictor of response to electroconvulsive therapy in patients with comorbid major depressive disorder and posttraumatic stress disorder.
Watts BV; Groft A
J ECT; 2010 Sep; 26(3):213-7. PubMed ID: 20386115
[TBL] [Abstract][Full Text] [Related]
48. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
49. Association of electroconvulsive therapy-induced structural plasticity with clinical remission.
Takamiya A; Kishimoto T; Hirano J; Kikuchi T; Yamagata B; Mimura M
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110286. PubMed ID: 33621611
[TBL] [Abstract][Full Text] [Related]
50. Effects of electroconvulsive therapy on EEG and cerebral blood flow in depression.
Silfverskiöld P; Rosén I; Risberg J
Eur Arch Psychiatry Neurol Sci; 1987; 236(4):202-8. PubMed ID: 3582428
[TBL] [Abstract][Full Text] [Related]
51. Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.
Østergaard SD; Speed MS; Kellner CH; Mueller M; McClintock SM; Husain MM; Petrides G; McCall WV; Lisanby SH;
J Affect Disord; 2020 Sep; 274():1134-1141. PubMed ID: 32663942
[TBL] [Abstract][Full Text] [Related]
52. Pivotal role of tissue plasminogen activator in the mechanism of action of electroconvulsive therapy.
Hoirisch-Clapauch S; Mezzasalma MA; Nardi AE
J Psychopharmacol; 2014 Feb; 28(2):99-105. PubMed ID: 24113086
[TBL] [Abstract][Full Text] [Related]
53. Structural network changes in patients with major depression and schizophrenia treated with electroconvulsive therapy.
Wolf RC; Nolte HM; Hirjak D; Hofer S; Seidl U; Depping MS; Stieltjes B; Maier-Hein K; Sambataro F; Thomann PA
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1465-1474. PubMed ID: 27424799
[TBL] [Abstract][Full Text] [Related]
54. Clinical outcome and memory function with maintenance electroconvulsive therapy: a retrospective study.
Abraham G; Milev R; Delva N; Zaheer J
J ECT; 2006 Mar; 22(1):43-5. PubMed ID: 16633206
[TBL] [Abstract][Full Text] [Related]
55. Interplay of Val66Met and BDNF methylation: effect on reward learning and cognitive performance in major depression.
Bakusic J; Vrieze E; Ghosh M; Pizzagalli DA; Bekaert B; Claes S; Godderis L
Clin Epigenetics; 2021 Jul; 13(1):149. PubMed ID: 34325733
[TBL] [Abstract][Full Text] [Related]
56. EFFICACY AND LONG-TERM CLINICAL OUTCOME OF COMORBID POSTTRAUMATIC STRESS DISORDER AND MAJOR DEPRESSIVE DISORDER AFTER ELECTROCONVULSIVE THERAPY.
Ahmadi N; Moss L; Simon E; Nemeroff CB; Atre-Vaidya N
Depress Anxiety; 2016 Jul; 33(7):640-7. PubMed ID: 26555786
[TBL] [Abstract][Full Text] [Related]
57. BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study.
Huang XB; Huang X; He HB; Mei F; Sun B; Zhou SM; Yan S; Zheng W; Ning Y
Neuropsychiatr Dis Treat; 2020; 16():901-908. PubMed ID: 32308393
[TBL] [Abstract][Full Text] [Related]
58. Multicenter randomized controlled trial of bifrontal, bitemporal, and right unilateral electroconvulsive therapy in major depressive disorder.
Su L; Jia Y; Liang S; Shi S; Mellor D; Xu Y
Psychiatry Clin Neurosci; 2019 Oct; 73(10):636-641. PubMed ID: 31260569
[TBL] [Abstract][Full Text] [Related]
59. Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels.
Rapinesi C; Kotzalidis GD; Curto M; Serata D; Ferri VR; Scatena P; Carbonetti P; Napoletano F; Miele J; Scaccianoce S; Del Casale A; Nicoletti F; Angeletti G; Girardi P
Psychiatry Res; 2015 Jun; 227(2-3):171-8. PubMed ID: 25910420
[TBL] [Abstract][Full Text] [Related]
60. Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients.
Lin CH; Chen MC; Lee WK; Chen CC; Huang CH; Lane HY
Neuropsychobiology; 2013; 68(2):110-5. PubMed ID: 23881232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
